Internal Medicine, Department of

Medicine & Life Sciences

1. Type 2 Diabetes Mellitus 100%
2. Coronary Artery Disease 93%
3. Liraglutide 79%
4. Gastric Bypass 57%
5. Urokinase Plasminogen Activator Receptors 54%
6. Weight Loss 47%
7. Glucose 45%
8. Overweight 41%
9. Exercise 40%
10. Placebos 39%
11. Hypoglycemia 36%
12. Metformin 36%
13. Mortality 35%
14. Heart Rate 34%
15. Orosomucoid 34%
16. C-Reactive Protein 33%
17. High-Protein Diet 30%
18. Cross-Over Studies 28%
19. Diet 28%
20. Therapeutics 28%
21. Insulin 27%
22. Ciliary Motility Disorders 27%
23. Inflammatory Bowel Diseases 26%
24. pasireotide 25%
25. Glucagon-Like Peptide-1 Receptor 25%
26. Randomized Controlled Trials 25%
27. Inflammation 24%
28. Cardiovascular Diseases 23%
29. Computed Tomography Angiography 22%
30. Insulin Resistance 22%
31. Acute Coronary Syndrome 22%
32. Myocardial Ischemia 21%
33. Heart Failure 21%
34. Carbohydrates 20%
35. Denmark 20%
36. Lipids 19%
37. Myocardial Infarction 19%
38. Blood Pressure 19%
39. Fasting 18%
40. Biomarkers 18%
41. Chest Pain 18%
42. Type 1 Diabetes Mellitus 17%
43. Hospital Emergency Service 17%
44. Fats 17%
45. Atrial Fibrillation 17%
46. Stroke 16%
47. Triglycerides 16%
48. Child 16%
49. Crohn Disease 15%
50. Body Composition 15%
51. Cohort Studies 15%
52. Urine 15%
53. Population 14%
54. Meta-Analysis 14%
55. Fatty Acids 14%
56. Body Weight 14%
57. Elderly 14%
58. Albuminuria 14%
59. Nursing Assessment 14%
60. trimethoprim sulfamethizole 14%
61. Abdominal Obesity 13%
62. Cardiology 13%
63. Monocytes 13%
64. Bariatrics 12%
65. Sitagliptin Phosphate 12%
66. Coronary Angiography 12%
67. Ulcerative Colitis 12%
68. Albumins 12%
69. Eastern Europe 12%
70. Acarbose 12%
71. Curriculum 12%
72. Obesity 12%
73. Cystic Fibrosis 11%
74. Hydroxymethylglutaryl-CoA Reductase Inhibitors 11%
75. Lung 11%
76. spirapril 11%
77. Glucagon-Like Peptide 1 11%
78. Confidence Intervals 11%
79. Body Mass Index 11%
80. Right Atrial Function 11%
81. Meals 11%
82. Incidence 11%
83. Geriatrics 10%
84. Glucose Tolerance Test 10%
85. Apolipoproteins M 10%
86. Echocardiography 10%
87. Lipolysis 10%
88. semaglutide 10%
89. Tomography 10%
90. Intra-Abdominal Fat 10%
91. lixisenatide 10%
92. Deprescriptions 10%
93. Ambulatory Care Facilities 10%
94. High-Protein Low-Carbohydrate Diets 9%
95. Geriatric Nursing 9%
96. Young Adult 9%
97. Malacoplakia 9%
98. Waist Circumference 9%
99. Early Warning Score 9%
100. Child Day Care Centers 9%